Fluad Trivalent 2024-2025 Syr is a seasonal influenza vaccine that protects against three strains of the influenza virus: an A/H1N1 strain, an A/H3N2 strain, and a B strain. It is manufactured by Seqirus and is approved for use in adults 65 years of age and older. Fluad Trivalent 2024-2025 Syr is administered as a single dose intramuscular injection.
Influenza is a contagious respiratory illness that can cause fever, cough, sore throat, runny nose, and body aches. In severe cases, influenza can lead to pneumonia, bronchitis, and even death. The flu vaccine is the best way to prevent influenza and its complications. Fluad Trivalent 2024-2025 Syr is an effective and safe vaccine that can help protect adults 65 years of age and older from the flu.
